The Astra vaccine unmasks the EU’s divide between the West and the desperate East

Sign up here for our daily coronavirus newsletter on what you need to know and subscribe to our Covid-19 podcast for the latest news and analysis.

When European drug regulators recognized a link between AstraZeneca Plc’s Covid-19 vaccine and a rare type of blood clot, it spread another dose of skepticism across the continent. But in the poorer east, doubts are more about the findings than about the shooting.

Most Western members of the European Union announced some restrictions on the use of the vaccine for younger age groups or stopped it altogether. The opposite happened in the east, with nine of the 11 nations in the region deciding to continue administering the shot to all adults.

“We do not believe unnecessary panic,” said Bulgarian Health Minister Kostadin Angelov, listing the benefits of the drug Astra. “We’re not going to be part of this war between the different companies, because it’s already visible.”

The former Eastern Bloc is home to almost a quarter of the EU’s 440 million population fighting to domesticate the pandemic. For these countries, they dominate the top 10 list in the world Per capita coronavirus deaths: Stopping a vaccine that is key to its supply is unthinkable because they cannot afford to slow down inoculation. Germany, in comparison, the number of daily vaccines against Covid-19 has doubled, while France reached a key milestone a week earlier.

Divided continent

Europe does not present a concerted course on the side effects of the Astra vaccine

Source: Bloomberg


The world has Astra’s shot for its price and ease of use and accounts for the majority of vaccines ordered by about a third of eastern EU members. The vaccine is more easily transported and stored than Moderna Inc.’s mRNA-based vaccines. and Pfizer-BioNTech, and the Anglo-Swedish company is committed to delivering up to 3 billion shots in 2021 on a nonprofit.

Read more: AstraZeneca’s vaccine drama runs the risk of prolonging the pandemic

Hungary, which moved away from the EU – orchestrated contract program and bought vaccines directly from Russia and China, has also tried to express its support for Astra.

“The debate over the AstraZeneca vaccine should be seen as a business struggle between drug manufacturers rather than valid opinions about medical risks,” Gergely Gulyas, the minister responsible for the office of the prime minister.

A day earlier, EU and UK regulators said yes a possible link between Astra shooting and blood clots, although both said the benefits of most people outweighed the risks, as the coronavirus remains full. Britain, of whom the vaccination program is well ahead of the rest of the continent, now it is recommended to get another under 30 years old.

BULGARIA-HEALTH-VIRUS-VACCINATION

A health worker checks the health of a patient before administering the AstraZeneca vaccine to the mayor of the village of Gardevtsi in Bulgaria.

Photographer: Nikolay Doychinov / AFP / Getty Images

In Bulgaria, the poorest and least vaccinated nation in the EU, the most expensive vaccines were used to inoculate priority groups, such as doctors and teachers. Astra is the most accessible to the general public.

The country’s inoculation effort was already over marked by poor organization and a 37% refusal rate among its 7 million citizens to get vaccinated, according to a March survey by Exacta Research. Bulgaria will continue to apply the Astra trait to all age groups, but will offer a different blow to women at high risk of thrombosis, according to EMA recommendations, the health minister said.

.Source